Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci
Authors
Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland
Marek Bronk
Department of Clinical Microbiology, Hospital of the Medical University of Gdansk, Poland
Łukasz Naumiuk
Department of Clinical Microbiology, Hospital of the Medical University of Gdansk, Poland
DOI: https://doi.org/10.2478/ahem-2022-0047 | Journal eISSN: 1732-2693
Language: English
Page range: 333 - 338
Submitted on: Jan 3, 2022
Accepted on: May 11, 2022
Published on: Aug 9, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2022 Tomasz Jarzembowski, Agnieszka Daca, Wiesław J. Cubała, Marek Bronk, Łukasz Naumiuk, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.